XCUR NASDAQ
Exicure, Inc.
1W: -5.7%
1M: -10.8%
3M: -42.2%
YTD: -79.4%
1Y: -72.0%
3Y: -67.6%
5Y: -99.4%
$1.15
-0.03 (-2.54%)
Weekly Expected Move ±10.5%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$7.3M
52W Range1.05-9.48
Volume5,298
Avg Volume402,530
Beta3.62
Dividend—
Analyst Ratings
Company Info
CEOJungsoo Kim
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2018-05-22
Websiteexicuretx.com
400 Seaport Court
Redwood City, CA 94063
US
Redwood City, CA 94063
US
847 673 1700
About Exicure, Inc.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Latest News
Exicure gets Nasdaq compliance extension
Exicure Announces Board and Committee Changes
12 Health Care Stocks Moving In Thursday's After-Market Session
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Exicure HiTron Inc. | J-Other | 117,441 | $4.50 | 2026-07-08 |
| Exicure HiTron Inc. | J-Other | 253,195 | $4.50 | 2026-06-26 |
| Exicure HiTron Inc. | J-Other | 123,456 | $4.50 | 2026-06-24 |
| Exicure HiTron Inc. | J-Other | 129,183 | $4.50 | 2026-06-23 |
| Miller Josh | F-InKind | 8 | $4.08 | 2026-02-16 |